{"version":"1.0","type":"link","title":"Intrapatient variation in PD-L1 expression and tumor mutational burden and implications for outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer.","author_name":"Li G 외","author_url":"https://prs-insight.online/author/Li%20G","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/98395","thumbnail_width":1200,"thumbnail_height":630}